| Treatment: | Nutrition |
|---|---|
| Transport Package: | Carton |
| Specification: | bottle |
| Trademark: | none |
| Origin: | China |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Moxifloxacin is indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae [MDRSP]), Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}